| Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 L Swadling, MO Diniz, NM Schmidt, OE Amin, A Chandran, E Shaw, ... Nature 601 (7891), 110-117, 2022 | 337 | 2022 |
| Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ... Science 377 (6603), eabq1841, 2022 | 292 | 2022 |
| Bone mineral lies mainly outside collagen fibrils: predictions of a composite model for osternal bone RMV Pidaparti, A Chandran, Y Takano, CH Turner Journal of biomechanics 29 (7), 909-916, 1996 | 202 | 1996 |
| Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Science immunology 5 (54), eabf3698, 2020 | 199 | 2020 |
| Mycobacterium tuberculosis Infection Induces HDAC1-Mediated Suppression of IL-12B Gene Expression in Macrophages A Chandran, C Antony, L Jose, S Mundayoor, K Natarajan, RA Kumar Frontiers in cellular and infection microbiology 5, 90, 2015 | 82 | 2015 |
| Hypothetical protein Rv3423.1 of Mycobacterium tuberculosis is a histone acetyltransferase L Jose, R Ramachandran, R Bhagavat, RL Gomez, A Chandran, ... The FEBS journal 283 (2), 265-281, 2016 | 62 | 2016 |
| Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study RK Gupta, J Rosenheim, LC Bell, A Chandran, JA Guerra-Assuncao, ... The Lancet Microbe 2 (10), e508-e517, 2021 | 57 | 2021 |
| Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational study M Belay, B Tulu, S Younis, DA Jolliffe, D Tayachew, H Manwandu, ... The Lancet Microbe 2 (6), e267-e275, 2021 | 45 | 2021 |
| Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections A Chandran, J Rosenheim, G Nageswaran, L Swadling, G Pollara, ... Cell Reports Medicine 3 (3), 2022 | 44 | 2022 |
| Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease G Pollara, CT Turner, J Rosenheim, A Chandran, LCK Bell, A Khan, ... Science translational medicine 13 (592), eabg7673, 2021 | 31 | 2021 |
| Development of a diagnostic compatible BCG vaccine against Bovine tuberculosis A Chandran, K Williams, T Mendum, G Stewart, S Clark, S Zadi, F Lanni, ... Scientific reports 9 (1), 17791, 2019 | 30 | 2019 |
| Mycobacterium bovis uses the ESX-1 Type VII secretion system to escape predation by the soil-dwelling amoeba Dictyostelium discoideum RE Butler, AA Smith, TA Mendum, A Chandran, H Wu, L Lefrançois, ... The ISME journal 14 (4), 919-930, 2020 | 25 | 2020 |
| Transposon libraries identify novel Mycobacterium bovis BCG genes involved in the dynamic interactions required for BCG to persist during in vivo passage in cattle TA Mendum, A Chandran, K Williams, HM Vordermeier, ... BMC genomics 20, 1-13, 2019 | 25 | 2019 |
| Molecular mechanisms in H2O2-induced increase in AT1 receptor gene expression in cardiac fibroblasts: A role for endogenously generated Angiotensin II V Anupama, M George, SB Dhanesh, A Chandran, J James, ... Journal of molecular and cellular cardiology 97, 295-305, 2016 | 24 | 2016 |
| HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19 S Astbury, CJ Reynolds, DK Butler, DC Muñoz‐Sandoval, KM Lin, ... Immunology 166 (1), 68-77, 2022 | 23 | 2022 |
| Structure-based discovery of lipoteichoic acid synthase inhibitors X Chee Wezen, A Chandran, RS Eapen, E Waters, L Bricio-Moreno, ... Journal of chemical information and modeling 62 (10), 2586-2599, 2022 | 16 | 2022 |
| Immune boosting by B. 1.1. 529 (Omicron) depends on previous SARS-CoV-2 exposure. Science 377, eabq1841 CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Munoz Sandoval, ... PubMed Abstract| Publisher Full Text, 2022 | 14 | 2022 |
| COVIDsortium investigators; COVIDsortium immune correlates network, Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... Sci. Immunol 5, 2020 | 10 | 2020 |
| Healthcare workers with mild/asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ... medRxiv, 2020.10. 13.20211763, 2020 | 7 | 2020 |
| Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response I Doykov, T Baldwin, J Spiewak, KC Gilmour, JM Gibbons, C Pade, ... Cell Reports Methods 2 (9), 2022 | 6 | 2022 |
